Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-02 @ 5:29 AM
Study NCT ID:
NCT07295366
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2025-12-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Open-label, Blinded Endpoint Assessment Study of Early PCSK9 Inhibitor Administration After Thrombectomy in Patients With Atherosclerotic Acute Ischemic Stroke.
Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XYFY2025-KL574-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None